http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200601641-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate | 2005-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-200601641-A1 |
| titleOfInvention | CRYSTAL COMPOSITION CONTAINING ESCYTAL PREMAX OXALATE |
| abstract | The present invention describes crystalline escitalopram oxalate particles having a wide particle size distribution or containing 0.01% (w / w) Z-4- (4-dimethylamino-1- (4-fluorophenyl) but-1-enyl) - 3-hydroxymethylbenzonitrile, where these particles are suitable for use in direct compression. In addition, the invention describes a new pharmaceutical unit dosage form containing such crystalline particles of escitalopram oxalate, as well as methods for producing such crystalline particles of escitalopram oxalate. Finally, the invention relates to a method for reducing the amount of hydroxyl-containing impurities in a solution of citalopram and escitalopram. |
| priorityDate | 2004-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.